APA Citatie

Ni, F., Huang, X., Chen, Z., Qian, W., & Tong, X. (2018). Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin. Sci Rep.

Chicago Style citaat

Ni, Fan, Xianbo Huang, Zhenzhen Chen, Wenbin Qian, en Xiangmin Tong. "Shikonin Exerts Antitumor Activity in Burkitt’s Lymphoma By Inhibiting C-MYC and PI3K/AKT/mTOR Pathway and Acts Synergistically With Doxorubicin." Sci Rep 2018.

MLA citatie

Ni, Fan, et al. "Shikonin Exerts Antitumor Activity in Burkitt’s Lymphoma By Inhibiting C-MYC and PI3K/AKT/mTOR Pathway and Acts Synergistically With Doxorubicin." Sci Rep 2018.